药剂师
人们还浏览了
计算自动化风险
低风险（21-40%）：这个级别的工作面临的自动化风险较低，因为它们需要技术和以人为中心的技能的混合。
有关这个分数是什么以及如何计算的更多信息可在这里找到。
用户投票
我们的访客投票认为，这个职业很可能会被自动化。 然而，员工可能会在我们生成的自动化风险等级中找到安慰，该等级显示有31%的机会会被自动化。
你认为自动化的风险是什么？
药剂师在未来20年内被机器人或人工智能取代的可能性有多大？
情感
以下图表在有大量投票数据时会显示。这些可视化图表展示了用户投票结果随时间的变化，提供了情感趋势的重要指示。
随着时间的推移的情绪（季度）
随着时间（每年）的情绪变化
增长
预计"Pharmacists"的工作空缺数量将在2033内增长5.4%
总就业人数和预计的职位空缺
更新的预测将在09-2024到期.
工资
在2023，'Pharmacists'的年度中位数工资为$136,030，或每小时$65。
'Pharmacists'的薪资比全国中位工资高183.0%，全国中位工资为$48,060。
随着时间推移的工资
体积
截至2023，在美国有331,700人被雇佣为'Pharmacists'。
这代表了全国就业劳动力的大约0.22%
换句话说，大约每457人中就有1人被雇佣为“Pharmacists”。
工作描述
根据医生和其他医疗从业者的处方分发药物，并向病人提供关于药物及其使用的信息。可能会就药物的选择、剂量、相互作用和副作用向医生和其他医疗从业者提供建议。
SOC Code: 29-1051.00
资源
在您的本地区搜索工作岗位
如果您正在考虑开始新的职业生涯，或者想要换工作，我们已经为您创建了一个方便的工作搜索工具，它可能会帮助您找到那个完美的新角色。
评论
Leave a comment
Pharmacists in clinically-focused roles face the greatest risk of displacement, as Physicians become more efficient in patient care due to AI advancements. This increased efficiency will likely reduce the need for Pharmacists and other healthcare professionals who currently fill gaps in care.
Furthermore, the advancement of AI will enable more clinicians outside of conventional medicine to retrain as Physicians, as medical schools become more flexible, affordable, and accessible. The pathway to becoming a Physician while working as a Pharmacist could soon be realized through part-time programs delivered as a series of short-term courses, potentially completed in as little as ten years. This shift could help meet the growing demand for Primary Care Physicians, where shortages persist.
For Pharmacists who remain in the field, the practice of Pharmacy will be completely different; it will be primarily driven by those competent enough to oversee the increasing implementation of AI and robotics. As AI and robotics usage expands, there will be a significant demand for Pharmacists who understand how to manage these technologies and ensure compliance with the stringent regulations governing their use.
AI will transform the pharmacy role, but humans will always need drugs, and human beings to talk to about those drugs.
In such a scenario, pharmacists might still be employed to monitor the operations of multiple pharmacies from a remote location in the event that systems malfunction or become overloaded.
The net effect of this shift could lead to a decreased demand for pharmacists, as pharmacy technicians demonstrate superior performance when utilizing AI compared to when they are assisted by pharmacists.
To maintain their current employment levels, pharmacists must demonstrate to the public that they excel in remotely monitoring, evaluating, updating, and maintaining pharmacy AI platforms compared to other professions.
Otherwise, there won’t be any justification for hiring pharmacists at the current rate or paying them at the same salary levels, especially if they do not possess greater skills than the pharmacy technicians using these technologies.
The other assumption is that AI will continue to progress exponentially. Based on current sentiment from most of the tech field is that LLM development has recently slowed significantly from its earliest developmental explosion. It's largest wall to development right now is retaining information permanence for the purposes of building knowledge not previously trained on, and avoiding non-factual "hallucinations". These are two critical problems that have yet to see widespread or effective solutions implemented.
Try replacing healthcare providers with a robot that can't remember critical personal details correctly or does not have the intuition to even ask based on human cues or complex social history - the majority of effective patient counselling and interaction in healthcare requires these functions.
While AI is set to change the role of clinical pharmacists in medication management, it is crucial to understand that AI is not expected to entirely replace them. Instead, AI will eliminate the need for pharmacists to directly prescribe and manage medications, opening up opportunities for collaboration in validating, certifying, and overseeing AI-driven prescribing software. This collaboration will be vital for ensuring the quality, accuracy, and ethical application of AI technology in healthcare. Pharmacists who embrace new roles in a technology-driven future will thrive, using their expertise and technological skills to advocate for their continued involvement in validating and enhancing the performance of AI-driven solutions in medication management. The pharmacists who cling to the past, where the physical presence of a pharmacist was required over digital presence and technological solutions, will be the ones left behind.
AI technology offers cost-effective solutions that surpass Clinical Pharmacists in medication reviews, questioning the need for non-physician involvement in assessing patients' medication effectiveness and appropriateness. As AI becomes more integrated into healthcare, it has the potential to improve the efficiency and effectiveness of physician-led prescribing, potentially rendering roles like Clinical Pharmacists obsolete in this aspect. This shift necessitates non-physician healthcare providers to adapt to changing responsibilities, as the tasks of prescribing and evaluating medication appropriateness and effectiveness, in a healthcare setting, will no longer be within their domain.
However, AI is not expected to completely replace Clinical Pharmacists and other healthcare professionals. Instead, it will remove the necessity for these professionals to directly prescribe and review medications, creating opportunities for collaboration in validating, certifying, developing, and managing AI-driven prescribing software in healthcare settings and software companies. This collaboration is crucial for ensuring the quality and reliability of the technology, as public trust in AI outcomes will require continuous validation and certification from other healthcare professionals.
The decision on who will provide these ongoing validations, whether it will be led by nurse practitioners, physician assistants, or clinical pharmacists, remains uncertain as the healthcare landscape evolves. If none of these professions takes on this role, physicians are likely to step in, seizing the chance to further establish themselves as the most qualified authorities in medication management.
While Nurse Practitioners, Physician Assistants, and Clinical Pharmacists have sought to expand their roles over time, the emergence of Artificial Intelligence (AI) software presents a significant shift. AI technology has the potential to disrupt this trend by offering cost-effective solutions that surpass the capabilities of Clinical Pharmacists in medication review. This development challenges the traditional arguments used to justify the involvement of non-physician providers in prescribing practices.
As AI software becomes more prevalent in healthcare, it is poised to enhance the efficiency of Physician-managed prescribing processes, potentially rendering the need for Clinical Pharmacists and other non-physician prescribers obsolete. This shift may prompt a reevaluation of the costs associated with employing these professionals outside their traditional scope. While AI is not expected to entirely replace Pharmacists and other healthcare providers, it will redirect their focus towards their core competencies, creating new opportunities for collaboration with Physicians and technology companies.
The evolving landscape of healthcare will require Pharmacists and other healthcare professionals to pivot towards roles that align with their original training, while also offering them opportunities to contribute to the development and maintenance of AI-driven prescribing software. This collaboration will be essential in ensuring the quality and reliability of these technological advancements, thereby fostering trust among the public in the outputs generated by such systems.
Physicians, unlike the general public, are trained experts in diagnosing and treating patients, with prescribing medications falling within their domain rather than that of pharmacists. While pharmacists traditionally excel in reviewing medication therapies, the integration of AI in data analysis is reshaping the landscape. This technological advancement is expected to reduce the necessity for clinical pharmacists to conduct extensive reviews in clinical settings. With physicians inputting data into AI systems for analysis and interpreting the outputs themselves, there will be a significant decrease in the previous reliance on pharmacists for medication optimization assessments.
The evolving role of AI may assume tasks previously handled by Clinical Pharmacists, such as ensuring prescribed medications align with patient needs and care goals. However, Pharmacists will still play a crucial role in training, updating, and refining AI systems to adapt to changing regulations and advancements in medicine. The responsibility will increasingly fall on Informatics Pharmacists, Information Technology Pharmacists, Data Scientists, Machine Learning Engineers, and Software Engineers, rather than solely on Clinical Pharmacists.
With technology playing an expanding role in the Pharmaceutical Industry, there will be a growing need for regulatory frameworks to supervise the sector. This shift will create a demand for Pharmacists specializing in Compliance and Regulatory Affairs within pharmacies. Increased site inspections will become necessary, requiring Pharmacists to intensify their monitoring efforts. Pharmacists will also face a rising burden of conducting independent assessments and detailed reporting to ensure that the technologies utilized comply with industry standards and regulations.
They had 0% human error in the years they launched it. This is so pharmacists can do more patient care which I think is a great idea. But for those who didn’t do residency vs those that did, I’m sure employers will choose the residency trained pharm over the non residency trained pharm.
Maybe the option to not do residency will diminish in the future.
There’s already low applicants as of this year with over 90% acceptance rates. It’s crazy bc seeing how much it was in demand ten years ago.
I think sooner or later other hospitals will follow, along with other companies in terms of AI and robots. Community pharmacists will have issues in the future if robotics are indeed what companies will invest in. Invest in robotics and you won’t have to pay 130-180k for each human to do the same job. They might be highly trained, but the job used to be on the job training, used to be Bachelor level. Lots of admin work. The whole PharmD was from greedy leaders that wanted to take advantage of the loans for higher education. Sucks.
关于这个职业请留下您的评论